why choose us

First received: December 07, 2022

Clinical Trial: Safety, Feasibility, and Tolerability of Sulforaphane in Children With Chronic Kidney Disease

Study Status: Completed

Recruit Status: RECRUITING

Condition: Pediatric Kidney Disease

Study Type: INTERVENTIONAL


Official Title: Safety, Feasibility, and Tolerability of Sulforaphane in Children With CKD

Brief Summary: This purpose of this study is to investigate potential new therapeutics in pediatric chronic kidney disease (CKD).The specific aims are to identify safe dosing and tolerability of sulforaphane (SFN) supplementation in children with moderate and advanced CKD.Secondary objectives will include preliminary exploration of changes in oxidative and inflammatory biomarkers in response to SFN supplementation in this population.

Read more